Effect of Hydration With Sodium Bicarbonate for Long-Term Clinical Outcomes in Patients With Chronic Kidney Disease Undergoing an Emergent Coronary Procedure
NCT00716001 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2008-07-15
Summary
This study is to evaluate the efficacy of sodium bicarbonate plus N-acetylcysteine for the prevention of contrast-induced nephropathy.
Conditions
- Chronic Renal Failure
Interventions
- DRUG
-
N-acetylcysteine
Sponsors & Collaborators
-
Osaka General Medical Center
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-31
- Primary Completion
- 2009-06-30
More Related Trials
-
Sodium Bicarbonate and N-Acetylcysteine for Nephroprotection in Acute Myocardial Infarction
NCT01218178 ·Status: COMPLETED
-
A Prospective, Randomized TrialComparing Oral N-Acetylcysteine and Intravenous Sodium Bicarbonate
NCT00579995 ·Status: TERMINATED ·Phase: NA
-
Hydration and Contrast-Induced Nephropathy in Primary Angioplasty
NCT00770614 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury
NCT01210456 ·Status: UNKNOWN ·Phase: PHASE3
-
Intravenous High Dose NAC and Sodium Bicarbonate for the Prevention of Contrast-induced Acute Injury
NCT01612013 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate Versus Saline for the Prevention of Contrast-induced Nephropathy
NCT00606827 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy
NCT00424320 ·Status: UNKNOWN ·Phase: PHASE3
-
The Use of Sodium Bicarbonate in the Prevention of Contrast Induced Nephropathy
NCT00494637 ·Status: TERMINATED ·Phase: NA
-
Early Hydration in Acute Myocardial Infarction
NCT01742130 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Hydration to Prevent Contrast Induced Nephropathy in PCI for ST-elevation Myocardial Infarction.
NCT00639912 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Serious Adverse Events Following Angiography
NCT01467466 ·Status: COMPLETED ·Phase: PHASE3
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Trial for Prevention of Contrast Nephropathy With Sodium Bicarbonate
NCT00312117 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Sodium Bicarbonate Solution in Decreasing the Incidence of Contrast Induced Nephropathy (CIN)
NCT00514150 ·Status: COMPLETED ·Phase: PHASE3
-
Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery
NCT05555511 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Contrast Induced Nephropathy With Sodium Bicarbonate
NCT00472563 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Sodium Bicarbonate to Reduce the Incidence of Contrast Induced Chronic Kidney Injury in Patients With Kidney Disease
NCT00930436 ·Status: TERMINATED ·Phase: PHASE3
-
High-Dose N-Acetylcysteine in Cardiac Surgery
NCT00332631 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy
NCT01093131 ·Status: WITHDRAWN ·Phase: PHASE4
-
N-Acetylcysteine for Preventing Renal Injury After Cardiac Surgery
NCT00188630 ·Status: COMPLETED ·Phase: PHASE3
-
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
NCT00950079 ·Status: UNKNOWN ·Phase: PHASE4
-
PROVOCATION Trial - PROphylactic intraVenOus Hydration for Contrast Agent Toxicity PreventION
NCT00130598 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Bicarbonate v Saline to Prevent Contrast Nephropathy
NCT00384995 ·Status: TERMINATED ·Phase: PHASE4
-
Ischemic Preconditioning to Prevent Acute Kidney Injury
NCT02167152 ·Status: COMPLETED ·Phase: NA
-
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
NCT00888290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3